XML 74 R61.htm IDEA: XBRL DOCUMENT v3.23.1
Capital Structure (Details) - USD ($)
1 Months Ended 12 Months Ended
Aug. 31, 2020
Sep. 30, 2018
Dec. 31, 2022
Dec. 31, 2021
Capital Structure (Details) [Line Items]        
Common stock, share authorized     40,000,000 40,000,000
Common stock, par value (in Dollars per share)     $ 0.0001 $ 0.0001
Warrant exercise price (in Dollars per share) $ 1.6      
Warrants expiration period 4 years      
Warrants convertible into common stock     116,903  
Preferred Stock [Member]        
Capital Structure (Details) [Line Items]        
Preferred stock, shares authorized     500,000  
Preferred stock, par value (in Dollars per share)     $ 0.001  
Common stock [Member]        
Capital Structure (Details) [Line Items]        
Common stock price per share (in Dollars per share)     $ 23  
Common stock, share authorized     40,000,000  
Common stock, par value (in Dollars per share)     $ 0.0001  
Series 1 Convertible Preferred Stock [Member]        
Capital Structure (Details) [Line Items]        
Convertible preferred stock conversion basis, description     As of December 31, 2022, each share of Series 1 Convertible Preferred Stock was convertible into 1.32230 shares of the Company’s common stock, subject to certain anti-dilution rights.  
Convertible preferred stock, terms of conversion, description     As of December 31, 2022 and 2021, there were 170,332 shares of Series 1 Convertible Preferred Stock outstanding, which were convertible into 225,231 shares of common stock.   
Series 1 Convertible Preferred Stock [Member] | Preferred Stock [Member]        
Capital Structure (Details) [Line Items]        
Preferred stock, shares authorized     250,000  
Series 2 Convertible Preferred Stock [Member]        
Capital Structure (Details) [Line Items]        
Preferred stock, designated     25,000  
Convertible preferred stock, shares issued upon conversion     20,000  
Gross proceeds from sale of shares (in Dollars)     $ 20,000,000  
Additional sale of shares     1,952  
Gross proceeds (in Dollars)     $ 1,950,000  
Preferred shares sold per share (in Dollars per share)     $ 1,000  
Stated value, percentage     10.00%  
Cumulative accrued dividends (in Dollars)     $ 19,084,376  
Preferred stock conversion into common stock, shares     266  
Description of warrants expiration     In connection with the issuance of Series 2 Convertible Preferred Stock in June 2016, the Company issued to the placement agent in such offering warrants exercisable for 439 shares of Series 2 Convertible Preferred Stock at an initial exercise price of $1,250 per share, which expire seven years after the date of issuance.   
Warrant [Member]        
Capital Structure (Details) [Line Items]        
Warrants exercisable for shares of common stock   5,750,000 1,055,184  
Warrant exercise price (in Dollars per share)   $ 1.25 $ 1.25  
Description of warrants expiration   The warrants were immediately exercisable and expire five years from the date of issuance. The warrants are exercisable at $1.25 per share of common stock and expire on September 28, 2023.  
Issuance of warrants     40,000  
Expenses (in Dollars)       $ 522,808
Weighted average grant date fair value (in Dollars per share)       $ 1.63
Warrant [Member] | Consulting Agreement [Member]        
Capital Structure (Details) [Line Items]        
Warrant exercise price (in Dollars per share)     $ 1.25  
Description of warrants expiration     The warrants are immediately exercisable and expire following the close of business on June 30, 2023.  
Warrant, description     As part of a consulting agreement with XLR8 Capital Partners LLC (the “Consulting Agreement”), an entity of which the Company’s Chairman is manager, the Company agreed to issue 40,000 warrants to XLR8 Capital Partners LLC monthly for 12 months beginning on March 1, 2019 at an exercise price of $1.25 per share or, if the closing share price on the last day of the month exceeds $1.25, then such exercise price will be 110% of the closing share price.